Highlights from ECOG-ACRIN Cancer Research fall 2024 meeting
The ECOG-ACRIN Fall 2024 Group Meeting was held from November 6-8 in Fort Lauderdale.
The ECOG-ACRIN Cancer Research Group’s semi-annual meetings showcase the latest in cancer research, focusing on prevention, imaging, diagnosis, and treatment. They provide a platform for academic exchange among physicians, researchers, patient advocates, and others, offer education on patient engagement in clinical research, and reinforce compliance with Group policies. The meetings also include non-CME training workshops for research professionals. They are open to researchers, staff from member institutions, patient advocates, industry representatives, and invited guests.
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) is a global network of nearly 1,400 academic and community-based cancer centers, involving over 21,000 oncology professionals. The organization designs and conducts cancer research for adults at risk of or diagnosed with cancer. ECOG-ACRIN is a key component of the National Cancer Institute’s National Clinical Trials Network (NCTN) and a Research Base for the NCI Community Oncology Research Program (NCORP). It is funded primarily by the NCI, with additional support from private sector collaborations and philanthropy.
“Congratulations to the Fall 2024 recipients of the Edith Peterson Mitchell, MD Health Equity Travel Scholarship!”
“So well deserved! Heather Hwakelee receives the ECOG-ACRIN Cancer Research Group Remarkable Mentor to Women Award Thank you Dr Wakelee for your intentional leadership for women in thoracic oncology and always opening doors for so many of us. Forever grateful for your mentorship/sponsorship.”
“Great first ECOG-ACRIN Cancer Research meeting, not only learning about science & trial design but also catching up with friends.”
“Excellent talk by Dr. Patnaik on clonal hematopoiesis at ECOG-ACRIN Cancer Research fall 2024 meeting.”
“Fantastic ECOG-ACRIN Cancer Research meeting with stellar colleagues with ideas for novel trials and real world data!”
“Dustin Deming of UW Health | Carbone Cancer Center delivers the 2024 Young Investigator Awardee Lecture at our Fall Group Meeting: Future Strategies for Precision Targeting of Cancer Therapeutics.”
“The day GU oncologists decided to go to the thoracic committee to show our support for Suzanne Cole real world trial. Real world data for real world patients.”
“Elephants rare get cancer. Why?
Mrinal Patnaik explains at the ECOG-ACRIN Cancer Research meeting. They gave 40 copies of the p53 tumor suppressor gene. (Humans have 2 copies).
Their cells commit suicide at the first hint of abnormality! Nipping cancer in the bud. Apparently no studies show evidence of visceral cancer in elephants, even on post mortem.
Clonal hematopoiesis mutations are highly prevalent and associated with cancer. But for me the question is can we really do anything about it? Great talk Mrinal Patnaik.”
“A breathtaking presentation by Mrinal Patnaik at the ECOG-ACRIN Cancer Research fall meeting was a tour de force—an inspiring review of the entire Clonal Hematopoiesis landscape, from foundational discoveries to potential clinical applications.”
“My first ECOG-ACRIN Cancer Research meeting is in the books. Inspiring work from incredible clinician-scientists. Grateful for the support from Dr. John M. Kirkwood. Shoutout to star fellow Dr. Urvashi Mitbander Joshi for a fantastic talk on melanoma prevention trial.”
“The future of oncology is bright and full of talent. Hanging out with Drs LaDonna Kearse & Ayo Falade future SurgOnc and HemOnc Mayo Clinic trainees at ECOG-ACRIN Cancer Research Fall Meeting.”
“PrE1702 study chair Suzanne Cole explains why our new Real Wold Data Registry Study is so important at the ECOG-ACRIN Cancer Research Fall 2024 Group Meeting. Learn more.”
“The ECOG Myeloma group is in my opinion is a great collection of clinicians in myeloma. We had our meeting yesterday and the collaboration, new science and working together to move the field forward is breathtaking Led by fearless leader Vincent Rajkumar along with Shaji Kumar, Natalie Callander, Natasha Edwin, Sagar Lonial, Jonathan Kaufman, Ajay Nooka, Yelak Biru, Mike Thompson, Dr. Baljevic.
Two other persons who do awesome biostats are Dr. Susanna Jacobus and Dr. Zihan Wei. Their work in innovative designs, QOL, PRO’s are awesome Also Dr. Rich Little from the NCI who guides us and the NCI MM steering committee.
Also want to acknowledge numerous other physicians who are community representatives and accruing in the trials and providing scientific feedback.”
“ECOGAcrin Fall Meeting – It’s all about the selfies and research collaborations Representing Sylvester Comprehensive Cancer Center research program at this meeting.”
“Great presentations by Dr. Shaalan Beg of the NCI and Dr. Marie Bradley of FDA on ‘Novel Clinical Trial Approaches’ and ‘Real World Evidence Demonstration Projects,’ respectively! Thanks for joining us!”
More posts featuring ECOG-ACRIN on oncodaily.com
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023